OTI-030

DB05648InvestigationalSmall molecule

Investigated for use/treatment in knee replacement.

Primary indication
Investigated for use/treatment in knee replacement.Curator reviewed
Code names
OTI-030

What you can answer from here — as of April 02, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of OTI-030, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In